Mounjaro, a recently released medication for type 2 diabetes, has gained significant recognition in the medical community. This groundbreaking drug, classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, https://zubaircegs094295.jts-blog.com/34677849/mounjaro-unveiling-the-benefits-and-risks-of-this-new-diabetes-drug